Drug intelligence / Profile preview

Fenghan formula

Development stage: Unknown
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Fenghan formula is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of post-infectious cough (PIC). It is specifically formulated for patients exhibiting the "wind-cold attacking lung" pattern, a TCM diagnostic category characterized by symptoms such as cough, itchy throat, and sensitivity to cold. The formula is designed to dispel wind, dissipate cold, and ventilate the lungs to relieve cough symptoms. In clinical research, it is being evaluated in two forms—granules and decoctions—to compare their efficacy and safety in adult populations.

Other names: Fenghan granulesFenghan decoctionWind-Cold formula

Beyond the preview

Go deeper on Fenghan formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fenghan formula.

Explore the full profile